Manager × security

Avoro Capital Advisors LLC KYMR holdings history

Who else holds this security? →

KYMERA THERAPEUTICS INC · CUSIP 501575104 · CIK 1633313

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Avoro Capital Advisors LLC reported 7.47M KYMR (shares), valued at $857.13M, or 7.70% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
7.70%
Shares
7.47M
7,474,747
Reported value
$857.13M
USD

Shares unchanged; reported value increased 37.68%, and weight changed +1.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20267.70%7,474,747SEC filing ↗Filed Aug 14, 2026
Q1 20266.13%7,474,747SEC filing ↗Filed May 15, 2026
Q4 20255.72%7,474,747SEC filing ↗Filed Mar 16, 2026Amended
Q3 20254.65%6,350,000SEC filing ↗Filed Nov 14, 2025
Q2 20255.01%6,555,555SEC filing ↗Filed Aug 14, 2025
Q1 20252.76%6,460,000SEC filing ↗Filed May 15, 2025
Q4 20242.93%5,150,000SEC filing ↗Filed Feb 14, 2025
Q3 20243.11%4,500,000SEC filing ↗Filed Nov 14, 2024
Q2 20241.55%3,888,888SEC filing ↗Filed Aug 14, 2024
Q1 20241.82%3,888,888SEC filing ↗Filed May 15, 2024
Q4 20231.33%3,775,000SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 20231.33%3,775,000$96.11MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20241.82%3,888,888$156.33MShares increased 3.02%; reported value increased 62.66%, and weight changed +0.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20241.55%3,888,888$116.08MShares unchanged; reported value decreased 25.75%, and weight changed -0.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20243.11%4,500,000$212.99MShares increased 15.71%; reported value increased 83.48%, and weight changed +1.56 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20242.93%5,150,000$207.18MShares increased 14.44%; reported value decreased 2.72%, and weight changed -0.18 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20252.76%6,460,000$176.81MShares increased 25.44%; reported value decreased 14.66%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20255.01%6,555,555$286.08MShares increased 1.48%; reported value increased 61.80%, and weight changed +2.25 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20254.65%6,350,000$359.41MShares decreased 3.14%; reported value increased 25.63%, and weight changed -0.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20255.72%7,474,747$581.61MShares increased 17.71%; reported value increased 61.82%, and weight changed +1.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Mar 16, 2026
Q1 20266.13%7,474,747$622.57MShares unchanged; reported value increased 7.04%, and weight changed +0.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20267.70%7,474,747$857.13MShares unchanged; reported value increased 37.68%, and weight changed +1.57 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Avoro Capital Advisors LLC · KYMERA THERAPEUTICS INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1633313","quarter":"2026Q2","cusip":"501575104"}

get_institutional_manager_history
{"cik":"1633313","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.